Biocept Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BIOC Nasdaq 2834 http://www.biocept.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biocept Inc

Biocept Announces Pricing of $2.5 Million Registered Direct Offering Priced at Market - Sep 21st, 2018 5:00 am
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer - Sep 10th, 2018 6:05 am
Biocept's Target Selector Platform Featured in Two Poster Presentations at the IASLC 19th World Conference on Lung Cancer - Sep 6th, 2018 6:05 am
Highmark Health's VITAL Innovation Program testing benefits of Biocept's liquid biopsy platform for improving outcomes and lowering costs of treatment for patients with non-small cell lung cancer - Aug 23rd, 2018 8:30 am
The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue - Aug 15th, 2018 6:48 am
Biocept Reports Second Quarter 2018 Financial Results - Aug 14th, 2018 2:05 pm
Biocept to Release Second Quarter 2018 Financial Results and Host Investor Conference Call on August 14, 2018 - Aug 9th, 2018 2:05 pm
Biocept Announces $11.6 Million in Expected Gross Proceeds from Recently Expired Rights Offering - Aug 9th, 2018 6:05 am
Biocept Announces Agreement with Managed Care Plan to Study the Benefits of Implementing Liquid Biopsy to Improve Patient Outcomes and Lower Healthcare Costs - Aug 6th, 2018 6:05 am
Biocept Awarded Patent in Canada for its Target Selector CTC Platform - Aug 2nd, 2018 6:05 am
European Patent Granted for Biocept's Target Selector Oncogene Mutation Enrichment and Detection Platform - Jul 31st, 2018 6:05 am
Biocept and UC San Diego Moores Cancer Center Announce Collaboration to Study Feasibility of Liquid Biopsy to Predict Disease Recurrence in Solid Tumors and Response to Therapy - Jul 23rd, 2018 6:05 am
Biocept Reminds Investors of Today's Deadline to be a Shareholder of Record - Jul 19th, 2018 7:00 am
Biocept, Inc. (BIOC) Soars: Stock Adds 9.8% in Session - Jul 16th, 2018 6:39 am
Today's Research Reports on Stocks to Watch: Biocept and Johnson and Johnson - Jul 16th, 2018 6:10 am
Why RH, Biocept, and Lowe's Jumped Today - Jul 13th, 2018 2:49 pm
Why Biocept’s Stock Price Is Soaring Today - Jul 13th, 2018 2:25 pm
BIOC: What’s Going on With Biocept Stock? - Jul 13th, 2018 1:46 pm
Why Biocept, Inc. Is Rebounding Big-Time Today - Jul 13th, 2018 11:02 am
Biocept Rallies On Marketing Agreement For Proprietary Liquid Biopsy Tests - Jul 13th, 2018 9:00 am